Target intelligence / Profile preview

Citric acid cycle (TCA cycle (Tricarboxylic acid cycle), Krebs cycle)

Target
TCA cycle (Tricarboxylic acid cycle), Krebs cycle
Molecular classification
Other (Metabolic pathway; not a discrete molecule, enzyme, receptor, or single drug target)
01

Overview

The citric acid cycle, also known as the Krebs cycle or tricarboxylic acid (TCA) cycle, is a central metabolic pathway occurring in the mitochondrial matrix of eukaryotic cells (and cytosol of prokaryotes), in which acetyl-CoA derived from carbohydrates, fats, and proteins is oxidized to carbon dioxide, generating reducing equivalents (NADH, FADH₂) for ATP production via oxidative phosphorylation. The cycle also provides intermediates for amino acid synthesis, heme synthesis, and other biosynthetic processes, reflecting its role as an amphibolic (both anabolic and catabolic) pathway. While not a specific molecular target, defects in individual cycle enzymes are implicated in several diseases, and some drugs or therapeutic strategies attempt to target specific enzymes or metabolic nodes within or feeding into the citric acid cycle.

Other names
Krebs cycleSzent–Györgyi–Krebs cycleTCA cycleTricarboxylic acid cycle
02

Mechanism of action

Inhibition of glutaminolysis, Inhibition or correction of cycle enzyme mutations, Modulation of substrate availability (e.g., α-ketoglutarate supplementation), Correction of metabolic defects in enzyme deficiencies

03

Biological functions

Energy productionMetabolismBiosynthesis of amino acidsProvision of metabolic intermediatesCellular respiration
04

Disease associations

CancerNeurodegenerative disease (e.g., Leigh syndrome)Inborn errors of metabolism (e.g., citrullinemia)Other metabolic disorders
05

Safety considerations

Broad impact on cellular energy metabolismpotential for tissue toxicity (from broad metabolic inhibition)off-target effectsrisk of impairing essential biosynthetic and metabolic processes
06

Interacting drugs

CB-839 (GLS inhibitor)

4 more in the full profile.

07

Biomarkers

Mutations or expression levels of citric acid cycle enzymes (e.g., SDH, isocitrate dehydrogenase)metabolic intermediates (e.g., citrate, succinate, fumarate, α-ketoglutarate) in blood or tumors

Beyond the preview

Go deeper on Citric acid cycle (TCA cycle (Tricarboxylic acid cycle), Krebs cycle).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Citric acid cycle (TCA cycle (Tricarboxylic acid cycle), Krebs cycle).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call